Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MCS - US5663301068 - Common Stock

15.77 USD
+0.08 (+0.51%)
Last: 11/26/2025, 8:04:00 PM
15.77 USD
0 (0%)
After Hours: 11/26/2025, 8:04:00 PM
Fundamental Rating

4

Overall MCS gets a fundamental rating of 4 out of 10. We evaluated MCS against 80 industry peers in the Entertainment industry. While MCS is still in line with the averages on profitability rating, there are concerns on its financial health. MCS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCS had positive earnings in the past year.
In the past year MCS had a positive cash flow from operations.
In the past 5 years MCS reported 4 times negative net income.
Of the past 5 years MCS 4 years had a positive operating cash flow.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

MCS's Return On Assets of 0.77% is fine compared to the rest of the industry. MCS outperforms 61.25% of its industry peers.
With a decent Return On Equity value of 1.70%, MCS is doing good in the industry, outperforming 65.00% of the companies in the same industry.
The Return On Invested Capital of MCS (1.44%) is better than 62.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCS is significantly below the industry average of 9.33%.
Industry RankSector Rank
ROA 0.77%
ROE 1.7%
ROIC 1.44%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a Profit Margin of 1.02%. This is in the better half of the industry: MCS outperforms 62.50% of its industry peers.
MCS's Operating Margin of 2.41% is in line compared to the rest of the industry. MCS outperforms 60.00% of its industry peers.
MCS's Operating Margin has declined in the last couple of years.
MCS's Gross Margin of 38.48% is in line compared to the rest of the industry. MCS outperforms 48.75% of its industry peers.
MCS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.41%
PM (TTM) 1.02%
GM 38.48%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MCS is destroying value.
MCS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MCS has more shares outstanding
MCS has a better debt/assets ratio than last year.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MCS has an Altman-Z score of 1.61. This is a bad value and indicates that MCS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.61, MCS is in line with its industry, outperforming 57.50% of the companies in the same industry.
The Debt to FCF ratio of MCS is 101.21, which is on the high side as it means it would take MCS, 101.21 years of fcf income to pay off all of its debts.
MCS's Debt to FCF ratio of 101.21 is in line compared to the rest of the industry. MCS outperforms 56.25% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that MCS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.38, MCS perfoms like the industry average, outperforming 48.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 101.21
Altman-Z 1.61
ROIC/WACC0.2
WACC7.33%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MCS has a Current Ratio of 0.35. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MCS (0.35) is worse than 87.50% of its industry peers.
MCS has a Quick Ratio of 0.35. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.35, MCS is doing worse than 86.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 170.59% over the past year.
MCS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.28%.
MCS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.17% yearly.
EPS 1Y (TTM)170.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.77%
Revenue 1Y (TTM)6.28%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%-9.68%

3.2 Future

MCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.94% yearly.
MCS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.98% yearly.
EPS Next Y220.91%
EPS Next 2Y113.02%
EPS Next 3Y72.94%
EPS Next 5YN/A
Revenue Next Year4.95%
Revenue Next 2Y4.89%
Revenue Next 3Y4.51%
Revenue Next 5Y3.98%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

MCS is valuated quite expensively with a Price/Earnings ratio of 65.71.
MCS's Price/Earnings ratio is a bit cheaper when compared to the industry. MCS is cheaper than 67.50% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, MCS is valued quite expensively.
The Price/Forward Earnings ratio is 23.90, which indicates a rather expensive current valuation of MCS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCS indicates a somewhat cheap valuation: MCS is cheaper than 76.25% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MCS to the average of the S&P500 Index (36.12), we can say MCS is valued slightly cheaper.
Industry RankSector Rank
PE 65.71
Fwd PE 23.9
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MCS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MCS is cheaper than 80.00% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as MCS.
Industry RankSector Rank
P/FCF 287.57
EV/EBITDA 7.47
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MCS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MCS's earnings are expected to grow with 72.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y113.02%
EPS Next 3Y72.94%

3

5. Dividend

5.1 Amount

MCS has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
MCS's Dividend Yield is rather good when compared to the industry average which is at 44.93. MCS pays more dividend than 91.25% of the companies in the same industry.
MCS's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has been paying a dividend for at least 10 years, so it has a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

115.61% of the earnings are spent on dividend by MCS. This is not a sustainable payout ratio.
DP115.61%
EPS Next 2Y113.02%
EPS Next 3Y72.94%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
MCS Dividend Payout.MCS Dividend Payout, showing the Payout Ratio.MCS Dividend Payout.PayoutRetained Earnings

MARCUS CORPORATION

NYSE:MCS (11/26/2025, 8:04:00 PM)

After market: 15.77 0 (0%)

15.77

+0.08 (+0.51%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-25 2026-02-25/bmo
Inst Owners78.83%
Inst Owner Change1.85%
Ins Owners4.98%
Ins Owner Change-0.42%
Market Cap493.76M
Revenue(TTM)753.27M
Net Income(TTM)7.72M
Analysts84.44
Price Target24.48 (55.23%)
Short Float %4.09%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP115.61%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-25 2025-11-25 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.28%
Min EPS beat(2)1.25%
Max EPS beat(2)15.3%
EPS beat(4)2
Avg EPS beat(4)-16.67%
Min EPS beat(4)-73%
Max EPS beat(4)15.3%
EPS beat(8)4
Avg EPS beat(8)-321.71%
EPS beat(12)5
Avg EPS beat(12)-224.9%
EPS beat(16)8
Avg EPS beat(16)-143.33%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-3.13%
Max Revenue beat(2)1.76%
Revenue beat(4)3
Avg Revenue beat(4)1.45%
Min Revenue beat(4)-3.13%
Max Revenue beat(4)5.29%
Revenue beat(8)6
Avg Revenue beat(8)3%
Revenue beat(12)10
Avg Revenue beat(12)2.66%
Revenue beat(16)14
Avg Revenue beat(16)4.88%
PT rev (1m)-4%
PT rev (3m)-4%
EPS NQ rev (1m)-7.78%
EPS NQ rev (3m)-4.23%
EPS NY rev (1m)-18.09%
EPS NY rev (3m)-16.63%
Revenue NQ rev (1m)-2.58%
Revenue NQ rev (3m)-2.86%
Revenue NY rev (1m)-0.97%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 65.71
Fwd PE 23.9
P/S 0.66
P/FCF 287.57
P/OCF 5.61
P/B 1.09
P/tB 1.3
EV/EBITDA 7.47
EPS(TTM)0.24
EY1.52%
EPS(NY)0.66
Fwd EY4.18%
FCF(TTM)0.05
FCFY0.35%
OCF(TTM)2.81
OCFY17.82%
SpS24.06
BVpS14.51
TBVpS12.12
PEG (NY)0.3
PEG (5Y)N/A
Graham Number8.85
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.7%
ROCE 2.11%
ROIC 1.44%
ROICexc 1.45%
ROICexgc 1.59%
OM 2.41%
PM (TTM) 1.02%
GM 38.48%
FCFM 0.23%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 101.21
Debt/EBITDA 1.93
Cap/Depr 122.78%
Cap/Sales 11.45%
Interest Coverage 1.75
Cash Conversion 99.52%
Profit Quality 22.24%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 1.61
F-Score6
WACC7.33%
ROIC/WACC0.2
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.77%
EPS Next Y220.91%
EPS Next 2Y113.02%
EPS Next 3Y72.94%
EPS Next 5YN/A
Revenue 1Y (TTM)6.28%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%-9.68%
Revenue Next Year4.95%
Revenue Next 2Y4.89%
Revenue Next 3Y4.51%
Revenue Next 5Y3.98%
EBIT growth 1Y-11.37%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year312.54%
EBIT Next 3Y65.19%
EBIT Next 5Y51.8%
FCF growth 1Y-97.41%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y-13.25%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%

MARCUS CORPORATION / MCS FAQ

What is the fundamental rating for MCS stock?

ChartMill assigns a fundamental rating of 4 / 10 to MCS.


What is the valuation status for MCS stock?

ChartMill assigns a valuation rating of 5 / 10 to MARCUS CORPORATION (MCS). This can be considered as Fairly Valued.


What is the profitability of MCS stock?

MARCUS CORPORATION (MCS) has a profitability rating of 4 / 10.


What is the valuation of MARCUS CORPORATION based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MARCUS CORPORATION (MCS) is 65.71 and the Price/Book (PB) ratio is 1.09.


What is the expected EPS growth for MARCUS CORPORATION (MCS) stock?

The Earnings per Share (EPS) of MARCUS CORPORATION (MCS) is expected to grow by 220.91% in the next year.